Osaic Holdings
GLMD icon

Osaic Holdings’s Galmed Pharmaceuticals GLMD Stock Holding History

Osaic Holdings’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 7975
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7777
2025
Q4 		$3 Hold
1
– – ﹤0.01% 7793
2025
Q3 		$6 Hold
1
– – ﹤0.01% 7873
2025
Q2 		$9 Hold
1
– – ﹤0.01% 7692
2025
Q1 		$7 Hold
1
– – ﹤0.01% 7385
2024
Q4 		$15 Hold
1
– – ﹤0.01% 7336
2024
Q3 		$34 Hold
1
– – ﹤0.01% 7318
2024
Q2 		$14 Hold
1
– – ﹤0.01% 7346
2024
Q1 		$18 Hold
1
– – ﹤0.01% 7128
2023
Q4 		$24 Hold
1
– – ﹤0.01% 7196
2023
Q3 		$32 Buy
+1
New +$106 ﹤0.01% 7295

Other funds holding GLMD

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's GLMD Position: Q2 2026 in Review

Osaic Holdings held its Galmed Pharmaceuticals (GLMD) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7975.

Osaic Holdings first reported a position in GLMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $34 in Q3 2024. 11 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.

  • Osaic Holdings held 1 share of Galmed Pharmaceuticals worth $2 as of Q2 2026.
  • Osaic Holdings left its Galmed Pharmaceuticals share count unchanged in Q2 2026.
  • Galmed Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7975 holding.
  • Osaic Holdings first reported a position in Galmed Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Osaic Holdings's Galmed Pharmaceuticals position peaked at $34 in Q3 2024.
  • 11 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.